Abstract:Background and aims: Approximately 50% of patients with ST elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) experience microvascular no-reflow. Pre- and post-PCI sonothrombolysis has been shown to decrease infarct size and improve left ventricular (LV) systolic function in STEMI patients receiving urgent PCI. The aim of this study was to investigate whether post-PCI sonothrombolysis alone in STEMI patients with persistent ST elevation could reduce no-reflow and infarct size. Methods: Patients with STEMI with symptoms <12 hours who had persistent ST elevation (≤70% ST resolution) after primary PCI were randomized to sonothrombolysis or control. The primary end point was summed (Σ) ST elevation 60 minutes after study intervention. Secondary end points included infarct size, myocardial perfusion score, LV ejection fraction on cardiovascular magnetic resonance imaging at 2 months follow-up, and clinical outcome at 6-month follow-up. Results: Sixty-seven STEMI patients with persistent ST elevation after PCI were randomized (49 left anterior descending, 18 right coronary/left circumflex artery). No difference was observed in Σ ST elevation 60 minutes after study intervention (mean difference, 0.6 mm; 95% CI, -1.1 to 2.2, P = .50). Complete ST resolution occurred in 14 (40%) of patients treated with sonothrombolysis compared to 6 (19%) of controls (P = .16). Myocardial perfusion score index (1.5 ± 0.3 vs 1.5 ± 0.3, P = .93), infarct size (18.0% ± 10% vs 16.8% ± 11%; P = .29) and LV ejection fraction on cardiovascular magnetic resonance (46% ± 8% vs 47% ± 11% in the control group; P = .86) were comparable. Incidence of all-cause death, acute coronary syndrome, and hospital admission for heart failure at 6-month follow-up was similar between the groups (sonothrombolysis, 2; control, 5). Conclusions: In STEMI patients with persistent ST elevation after PCI, post-PCI sonothrombolysis did not result in more ST resolution or smaller infarct size compared to control subjects. The incidence of the combined clinical end points was remarkably low in this high-risk patient population.

Interventional thrombus modification in STEMI

Emerging Adjuvant Thrombolytic Therapies for Acute Ischemic Stroke Reperfusion

Antithrombotic therapy for patients with STEMI undergoing primary PCI

Overview of Mechanical Thrombectomy Techniques

Guest Editorial: An Update on Stroke Intervention

Interventional therapy for venous thromboembolism

Thromboembolic stroke complicating coronary intervention: acute evaluation and management in the cardiac catheterization laboratory

Advances in Intravascular Imaging Techniques to Guide Stent Thrombosis Prevention and Researching Mechanisms

Insights from thrombi retrieved in stroke due to large vessel occlusion

Intracranial atherosclerosis update for neurointerventionalists

Pathophysiology and Treatment of the No-Reflow Phenomenon in ST-Segment Elevation Myocardial Infarction: Focus on Low-Dose Fibrinolysis during Primary Percutaneous Intervention

Sub-Intimal Tracking and Re-Entry and Investment Procedures: Current Applications and Future Directions

Stentriever Thrombectomy Failure: A Challenge in Stroke Management

Spontaneous reperfusion in STEMI: Its mechanisms and possible modulation

Resurrecting an Old Concept in Contemporary Practice

Thrombolysis for acute ischaemic stroke: current status and future perspectives

Interfacility Transfer for Thrombectomy: A Promising Therapeutic Window

Sonothrombolysis in Patients With ST-Elevation Myocardial Infarction With Electrocardiographic No-Reflow After Percutaneous Coronary Intervention: A Randomized Controlled Trial

Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management

Interventional therapy of the acute coronary syndromes

Antithrombotic therapy for transcatheter structural heart intervention